Staphylococcus aureus osteomyelitis in Hawaii

Clinical Pediatrics
Guliz ErdemMarian Melish

Abstract

The clinical and laboratory findings and outcomes of methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) Staphylococcus aureus osteomyelitis have not been studied in Hawaii. Retrospective inpatient chart reviews of 62 culture-proven osteomyelitis patients between 1996 and 2007 were performed. Fifteen patients (24%) had MRSA infection, and 47 patients (76%) had MSSA infection. Length of stay, chronic health problems, total duration of fever, and length of treatment were not significantly different between MRSA- and MSSA-infected patients. The peak erythrocyte sedimentation rate and C-reactive protein values were higher among MRSA infected patients (P values: .009 and .003, respectively).The systemic complication rate was higher in MRSA-infected patients (P value: .018). Differing from other pediatric staphylococcal infections in Hawaii, the majority of the patients had MSSA infection. Pacific Islander and Native Hawaiian ethnicities were affected disproportionately and had MRSA infection more frequently. MRSA-infected patients had frequent surgical procedures and systemic complications.

References

Feb 1, 1977·American Journal of Diseases of Children·J P HieberG H McCracken
Nov 1, 1975·American Journal of Diseases of Children·V Q DichK C Haltalin
Jul 1, 1992·The Journal of Bone and Joint Surgery. British Volume·M A CraigenJ S Hackett
Nov 1, 1985·Pediatric Infectious Disease·W R JarvisJ M Hughes
Mar 5, 1998·JAMA : the Journal of the American Medical Association·B C HeroldR S Daum
Dec 16, 1998·The Pediatric Infectious Disease Journal·A KarwowskaT Jadavji
Nov 26, 1999·The Pediatric Infectious Disease Journal·A L FrankP C Schreckenberger
Sep 18, 2001·JAMA : the Journal of the American Medical Association·A V GroomJ E Cheek
Aug 14, 2002·Journal of Paediatrics and Child Health·M B VinodJ R Carapetis
Dec 20, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sara E CosgroveYehuda Carmeli
Jan 11, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cassandra D SalgadoDavid P Calfee
Feb 21, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John J EngemannKeith S Kaye
Jul 13, 2004·The Pediatric Infectious Disease Journal·Steven C BuckinghamFred C Tenover
Jul 22, 2004·The Annals of Pharmacotherapy·Brian J KoppEdward P Armstrong
Aug 6, 2004·The Pediatric Infectious Disease Journal·Gerardo Martínez-AguilarSheldon L Kaplan
Oct 19, 2004·International Orthopaedics·Melissa Rossaak, Rocco P Pitto
Mar 11, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Sara E CosgroveYehuda Carmeli
Apr 19, 2005·Pediatric Surgery International·D MalciusA Kilda
Apr 21, 2005·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Luca LazzariniJon T Mader
May 24, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sheldon L KaplanEdward O Mason
Jun 21, 2005·Diagnostic Microbiology and Infectious Disease·Thomas P Lodise, Peggy S McKinnon
Aug 18, 2006·The New England Journal of Medicine·Gregory J MoranUNKNOWN EMERGEncy ID Net Study Group
Sep 23, 2006·The Journal of Infection·Concepcion F EstivarizDaniel B Jernigan
Jan 3, 2007·The Journal of Infection·Naval G DaverA Clinton White
Feb 28, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Simone ShurlandMary-Claire Roghmann
Oct 18, 2007·JAMA : the Journal of the American Medical Association·R Monina KlevensUNKNOWN Active Bacterial Core surveillance (ABCs) MRSA Investigators
Feb 9, 2008·Emerging Infectious Diseases·Eili KleinRamanan Laxminarayan
Apr 15, 2008·Emergency Medicine Clinics of North America·Thomas R WallinBradley W Frazee
May 2, 2008·Current Opinion in Infectious Diseases·Stefan WeichertSaul N Faust
Jun 27, 2008·Journal of Pediatric Orthopedics·Jesús Saavedra-LozanoOctavio Ramilo

❮ Previous
Next ❯

Citations

Jul 29, 2016·The Journal of the American Academy of Orthopaedic Surgeons·Alexandre ArkaderKenneth Noonan
Dec 30, 2014·The Journal of the American Academy of Orthopaedic Surgeons·Albert Pendleton, Mininder S Kocher
Jun 9, 2016·Journal of Pediatric Orthopedics·Brad StoneHaemish Crawford
May 29, 2015·Clinical Microbiology Reviews·Steven Y C TongVance G Fowler

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Diabetic Medicine : a Journal of the British Diabetic Association
J Aragón-SánchezJ V Beneit-Montesinos
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Gregory A FiliceRuth Lynfield
Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
Timothy S ThomasonDale Ehmer
© 2021 Meta ULC. All rights reserved